Patents by Inventor Aryn Alaine Price

Aryn Alaine Price has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CAS9-nucleic acid complexes and uses related thereto
    Patent number: 11312945
    Abstract: This disclosure relates to Cas9-nucleic acid complexes and uses related thereto. In certain embodiments, the disclosure contemplates transgenic plants and animals genetically engineered to express Cas9-nucleic acid complexes disclosed herein. In certain embodiments, the disclosure relates to methods of treating or preventing, diseases, conditions, cancer, viral infections or other pathogenic infection using vectors configured to express a Cas9-nucleic acid complex disclosed herein.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: April 26, 2022
    Assignee: Emory University
    Inventors: David S. Weiss, Arash Grakoui, Timothy R. Sampson, Aryn Alaine Price
  • CAS9-NUCLEIC ACID COMPLEXES AND USES RELATED THERETO
    Publication number: 20200354700
    Abstract: This disclosure relates to Cas9-nucleic acid complexes and uses related thereto. In certain embodiments, the disclosure contemplates transgenic plants and animals genetically engineered to express Cas9-nucleic acid complexes disclosed herein. In certain embodiments, the disclosure relates to methods of treating or preventing, diseases, conditions, cancer, viral infections or other pathogenic infection using vectors configured to express a Cas9-nucleic acid complex disclosed herein.
    Type: Application
    Filed: July 10, 2019
    Publication date: November 12, 2020
    Inventors: David S. Weiss, Arash Grakoui, Timothy R. Sampson, Aryn Alaine Price
  • Cas9-nucleic acid complexes and uses related thereto
    Patent number: 10544405
    Abstract: This disclosure relates to Cas9-nucleic acid complexes and uses related thereto. In certain embodiments, the disclosure contemplates transgenic plants and animals genetically engineered to express Cas9-nucleic acid complexes disclosed herein. In certain embodiments, the disclosure relates to methods of treating or preventing, diseases, conditions, cancer, viral infections or other pathogenic infection using vectors configured to express a Cas9-nucleic acid complex disclosed herein.
    Type: Grant
    Filed: January 15, 2014
    Date of Patent: January 28, 2020
    Assignee: Emory University
    Inventors: David S. Weiss, Arash Grakoui, Timothy R. Sampson, Aryn Alaine Price
  • CAS9-NUCLEIC ACID COMPLEXES AND USES RELATED THERETO
    Publication number: 20150353905
    Abstract: This disclosure relates to Cas9-nucleic acid complexes and uses related thereto. In certain embodiments, the disclosure contemplates transgenic plants and animals genetically engineered to express Cas9-nucleic acid complexes disclosed herein. In certain embodiments, the disclosure relates to methods of treating or preventing, diseases, conditions, cancer, viral infections or other pathogenic infection using vectors configured to express a Cas9-nucleic acid complex disclosed herein.
    Type: Application
    Filed: January 15, 2014
    Publication date: December 10, 2015
    Inventors: David S. Weiss, Arash Grakoui, Timothy R. Sampson, Aryn Alaine Price